Summary of Conference Call Notes Company Overview - The company discussed is **倍加洁** (Beijiajie), which operates in the **probiotic and dietary supplement industry**. The focus is on its subsidiary **善恩康** (Shanenkang) and its product line involving **AKK菌** (Akkermansia muciniphila). Key Points and Arguments - **Stock Price Volatility**: The company's stock experienced significant fluctuations, attributed to a general pullback in small-cap stocks within the beauty and health sector. However, the company's fundamentals remain strong, with no abnormalities reported [1]. - **Growth Projections**: The company anticipates stable growth in its contract manufacturing business through 2026. The subsidiary Shanenkang is expected to see rapid growth driven by the AKK菌 product line, with profit margins likely to improve [1]. - **Financial Performance**: For the first half of 2025, Shanenkang is projected to achieve revenue of **49.76 million yuan**, representing an increase of over **80%** year-on-year. The net profit is expected to be **8.38 million yuan**, with a net profit margin of approximately **17%** (compared to a loss in the same period of 2024) [1]. - **Customer Expansion**: The significant revenue growth is attributed to an increase in customer numbers and the successful launch of high-margin AKK菌 products. The company has established partnerships with brands such as **仙乐** (Xianle), **Wonderlab**, and **若羽臣** (Ruoyuchen) [1]. - **Revenue Forecast for AKK菌**: The company estimates that revenue from AKK菌 products will exceed **10 million yuan** in 2025, with expectations for exponential growth in 2026 [1]. Industry Insights - **AKK菌 Overview**: AKK菌, also known as "slim bacteria" or "longevity bacteria," is naturally found in the human gut and is associated with higher proportions in long-lived and lean populations. It has significant potential applications in enhancing metabolism and immune health [2]. - **Product Development**: In February 2025, Shanenkang's AKK PROBIO active probiotic became the first product globally to receive both live and inactivated bacteria GRAS certification from the U.S. [2]. - **Market Trends**: There has been a surge in dietary supplement brands launching AKK菌 products. For instance, **若羽臣** launched an AKK菌 product priced at **228 yuan** per bottle, focusing on scientific weight management and metabolism enhancement, achieving over **4 million yuan** in GMV within 20 days of launch [2]. - **Competitive Landscape**: Recently, the **斐萃** brand introduced the **AKK小银瓶** product, priced at **2997 yuan** for three bottles, each containing **100 billion TFU** of inactivated AKK菌. This indicates a growing market interest and application potential for AKK菌 products [2]. Additional Important Content - The ongoing development and marketing of AKK菌 products suggest a promising future for the probiotic segment, with increasing consumer awareness and demand for health supplements focusing on metabolic and immune health benefits [2].